Kirsch B, Dubois J, Zaiac M, Ahuja S, Chadha D. A Multi-Center, Open-Label Extension Study to Assess the Long-Term Safety, Tolerability and Pharmacokinetics, and Explore the Efficacy of Sofpironium Bromide Gel, 15% Applied Topically to Children/Adolescents, 9-16 Years, with Primary Axillary Hyperhidrosis. J of Skin [Internet]. 2020Oct.27 [cited 2024Sep.20];4(6):s116. Available from: https://dermsquared.com/skin/article/view/1089